Literature DB >> 11410486

Persistence of genetically altered fields in head and neck cancer patients: biological and clinical implications.

M P Tabor1, R H Brakenhoff, V M van Houten, J A Kummer, M H Snel, P J Snijders, G B Snow, C R Leemans, B J Braakhuis.   

Abstract

In 1953, Slaughter et al. [D. P. Slaughter et al., Cancer (Phila.), 6: 963-968, 1953] proposed the concept of field cancerization in patients with squamous cell carcinoma of the head and neck (HNSCC) and discussed its clinical significance for the development of second primary tumors and local recurrences. To define the process of field cancerization and its putative clinical implications, we analyzed genetic aberrations in HNSCC and the accompanying macroscopically normal mucosa. In 28 HNSCC patients, loss of heterozygosity was determined in tumor and five noncontiguous mucosal biopsies using eight microsatellite markers at 9p, 3p, and 17p. For patients who showed loss of heterozygosity in their mucosal biopsies, all margins of the surgical specimen were subsequently analyzed to determine the extension of the field. In these cases, additional markers at 8p, 13q, and 18q as well as p53 mutations were included to determine subclonal differences between field and tumor. Genetically altered fields were detected in 36% (10 of 28) of the HNSCC patients. The field varied in size between patients and consisted of genetically different subclones. In 7 of 10 cases, the field extended into the surgical margins. One particular patient with a genetically altered field in a surgical margin developed a local recurrence after 28 months of follow-up. Microsatellite analysis showed that this recurrence had more molecular markers in common with the nonresected premalignant field than with the original tumor, suggesting that this persistent field has progressed further into a new malignancy. Our data show that genetically altered mucosa remains after treatment in a significant proportion of HNSCC patients, which may explain in part the high frequency of local recurrences and second primary tumors. Adequate identification and risk assessment of these genetically altered fields may have profound implications for future patient management.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11410486

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  66 in total

1.  Impact of microsatellite alteration in surgical margins on local recurrence in oral cavity cancer patients.

Authors:  Jin-Ching Lin; Chen-Chi Wang; Rong-San Jiang; Wen-Yi Wang; Shih-An Liu
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-07-18       Impact factor: 2.503

Review 2.  The Stem Cell Network model: clinical implications in cancer.

Authors:  Rubén Cabanillas; José L Llorente
Journal:  Eur Arch Otorhinolaryngol       Date:  2008-09-20       Impact factor: 2.503

3.  DNA methylation: a marker for carcinogen exposure and cancer risk.

Authors:  Takeshi Nakajima; Shotaro Enomoto; Toshikazu Ushijima
Journal:  Environ Health Prev Med       Date:  2007-12-11       Impact factor: 3.674

4.  Histological and immunohistochemical evaluation of new epithelium after removal of oral leukoplakia with Nd:YAG laser treatment.

Authors:  Lucio Montebugnoli; Francesca Frini; Davide Bartolomeo Gissi; Andrea Gabusi; Fabio Cervellati; Maria Pia Foschini; Claudio Marchetti
Journal:  Lasers Med Sci       Date:  2011-06-18       Impact factor: 3.161

Review 5.  Delineating an epigenetic continuum in head and neck cancer.

Authors:  Maria J Worsham; Josena K Stephen; Kang Mei Chen; Shaleta Havard; Veena Shah; Glendon Gardner; Vanessa G Schweitzer
Journal:  Cancer Lett       Date:  2012-03-01       Impact factor: 8.679

6.  The color of cancer: Margin guidance for oral cancer resection using elastic scattering spectroscopy.

Authors:  Gregory A Grillone; Zimmern Wang; Gintas P Krisciunas; Angela C Tsai; Vishnu R Kannabiran; Robert W Pistey; Qing Zhao; Eladio Rodriguez-Diaz; Ousama M A'Amar; Irving J Bigio
Journal:  Laryngoscope       Date:  2017-07-28       Impact factor: 3.325

7.  Mutational Status of CDKN2A and TP53 Genes in Laryngeal Squamous Cell Carcinoma.

Authors:  Teodora A Todorova; Stanislav H Jordanov; Gergana S Stancheva; Ivan J Chalakov; Mincho B Melnicharov; Kuncho V Kunev; Vanio I Mitev; Radka P Kaneva; Teodora E Goranova
Journal:  Pathol Oncol Res       Date:  2014-08-23       Impact factor: 3.201

Review 8.  Molecular biology of squamous cell carcinoma of the head and neck.

Authors:  B Perez-Ordoñez; M Beauchemin; R C K Jordan
Journal:  J Clin Pathol       Date:  2006-05       Impact factor: 3.411

Review 9.  Prognostic factors, predictive markers and cancer biology: the triad for successful oral cancer chemoprevention.

Authors:  Jose Augusto Monteiro de Oliveira Novaes; William N William
Journal:  Future Oncol       Date:  2016-06-22       Impact factor: 3.404

10.  Analysis of microsatellite mutations in buccal cells from a case-control study for lung cancer.

Authors:  Jessica L Baumann; Ming Li; Aslak Poulsen; Nicholson S Chadwick; Qiuyin Cai; Christine H Chung; Yu Shyr; Jørgen H Olsen; Wei Zheng; Robbert J C Slebos
Journal:  Cancer Epidemiol       Date:  2011-11-06       Impact factor: 2.984

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.